Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

HIV-1 capsid protein and cyclophilin a as new targets for anti-AIDS therapeutic agents.

Infectious disorders drug targets - 1 Sept 2007

Li Jiebo, Tang Shixing, Hewlett Indira, Yang Ming

Abstract excerpt

The emergence of drug resistant mutations in current anti-HIV-1 drug regimens is an important determinant of the eventual drug failure. New drug development strategies that focus on either new targets or novel compounds are therefore critical for future effective viral suppression in HIV-1 infected individuals. Particularly, virus assembly and disassembly are attractive candidate processes for antiviral...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acquired Immunodeficiency Syndrome
Share to Anti-HIV Agents
Share to Capsid Proteins

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Cyclophilin A

Share to Drug Delivery Systems

Share to Drug Design

Share to Drug Resistance, Viral

Share to Virus Replication

Source

Identifiers

PMID: 17897064
DOI: 10.2174/187152607782110013

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

HIV-1 capsid protein and cyclophilin a as new targets for anti-AIDS therapeutic agents.PMID 17897064Read ↗

HIV-1 Capsid Inhibitors as Antiretroviral AgentsSemantic proximity Read ↗

Inhibitors of the HIV-1 capsid, a target of opportunitySemantic proximity Read ↗

HIV Capsid is a Tractable Target for Small Molecule Therapeutic InterventionSemantic proximity Read ↗

Covalent anti-HIV compound that induces HIV-1 capsid multimerization and degradation decomposes the viral coreSemantic proximity Read ↗

The primary mechanism for highly potent inhibition of HIV-1 maturation by lenacapavirSemantic proximity Read ↗

A small molecule, ACAi-028, with anti-HIV-1 activity targets a novel hydrophobic pocket on HIV-1 capsidSemantic proximity Read ↗

Interactions of HIV-1 Capsid with Host Factors and Their Implications for Developing Novel TherapeuticsSemantic proximity Read ↗

The Role of Capsid in the Early Steps of HIV-1 Infection: New Insights into the Core of the MatterSemantic proximity Read ↗

Inhibiting Early-Stage Events in HIV-1 Replication by Small-Molecule Targeting of the HIV-1 CapsidSemantic proximity Read ↗

HIV-1 capsid variability: viral exploitation and evasion of capsid-binding moleculesSemantic proximity Read ↗

Supercharged Assembly: A Broad-Spectrum Mechanism of Action for Drugs that Undermine Controlled HIV-1 Viral Capsid FormationSemantic proximity Read ↗

Dynamic allostery governs cyclophilin A-HIV capsid interplay.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.